Company Filing History:
Years Active: 1997
Title: Innovations by Inventor Warren E. Shrader
Introduction: Warren E. Shrader is an accomplished inventor based in Indianapolis, IN, known for his contributions to the field of protein chemistry. With a total of two patents, he has made significant advancements that benefit various applications, particularly in the pharmaceutical industry.
Latest Patents: One of Warren's notable patents is for the "Preparation of an acylated protein powder," which details a method for recovering acylated proteins as a powder. This innovative approach is particularly useful for proteins that resist isolation through isoelectric precipitation from aqueous solutions. The method involves adjusting the aqueous solution to near the isoelectric pH of the protein and adding a suitable alcohol concentration to form filterable particles at that pH.
Another significant patent by Warren is focused on "Reducing gelation of a fatty acid-acylated protein." This method processes fatty acid-acylated proteins, such as N-palmitoyl Lys.sup.B29 human insulin, with the inclusion of a citrate buffering agent as the primary buffer. This innovation allows for higher protein concentrations and requires less stringent temperature control during processing, enhancing the efficiency of protein management.
Career Highlights: Warren E. Shrader's career is prominently associated with Eli Lilly and Company, a leading global pharmaceutical company. His work there has not only led to groundbreaking innovations in protein processing but has also positioned Eli Lilly at the forefront of medical advancements.
Collaborations: Throughout his career, Warren has collaborated with distinguished colleagues such as Jeffrey C. Baker and Brian A. Moser. These collaborations highlight the team-oriented environment in which Warren operates, contributing to shared innovations and advancements within the company.
Conclusion: Warren E. Shrader's innovative methodologies in protein chemistry exemplify the critical role of inventors in advancing pharmaceuticals and other industries. His patents not only push the boundaries of current scientific knowledge but also pave the way for future research and development in protein applications.